Los Angeles, CANCT02986984Now EnrollingIRB Ready

Diabetic Nephropathies Clinical Trial in Los Angeles, CA

Access cutting-edge diabetic nephropathies treatment through this clinical trial at a research site in Los Angeles. Study-provided care at no cost to qualified participants.

Sponsored by University of Pennsylvania

Quick Self-Assessment

See if you qualify for this Los Angeles location

Preparing your pre-screening questions…

Expert Care in Los Angeles

Access diabetic nephropathies specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related diabetic nephropathies treatment provided free

Apply for This Los Angeles Location

Check if you qualify for this diabetic nephropathies clinical trial in Los Angeles, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Los Angeles

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Los Angeles site if eligible
  4. 4Begin participation

About This Diabetic Nephropathies Study in Los Angeles

This is a prospective, observational, cohort study of patients with a clinical diagnosis of diabetes who are undergoing clinically indicated kidney biopsy. The intent is to collect, process, and study kidney tissue and to harvest blood, urine and genetic materials to elucidate molecular pathways and link them to biomarkers that characterize those patients have a rapid decline in kidney function (\> 5 mL/min/1.73m2/year) from those with lesser degrees of kidney function change over the period of observation. High through-put genomic analysis associated with genetic and biomarker testing will serve to identify key potential therapeutic targets for DKD by comparing patients with rapid and slow progression patterns. Each participating clinical site will search for, consent, harvest the biopsy sample, and enroll the participants as required for the TRIDENT protocol.

Sponsor: University of Pennsylvania

Who Can Participate

Inclusion Criteria

Type 1 and 2 Diabetes by American Diabetes Association (ADA) criteria
Willingness to comply with study requirements, including intention to fully participate in protocol-specified follow-up at a clinical study site
Able to provide informed consent
Adult participants
Planned medically indicated kidney biopsy, prescribed by a practicing nephrologist

Exclusion Criteria

End Stage Renal Disease (ESRD), defined as chronic dialysis or kidney transplant
History of receiving dialysis for more than 30 days prior to biopsy
Institutionalized
Solid organ or bone marrow transplant recipient at time of first kidney biopsy
Less than 3-year life expectancy
History of active alcohol and/or substance abuse that in the investigator's assessment would impair the subject's ability to comply with the protocol
Unable to provide informed consent
Evidence of active cancer requiring treatment, other than non-melanoma skin cancer

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Los Angeles?

Yes, this clinical trial (NCT02986984) has an active research site in Los Angeles, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Diabetic Nephropathies Treatment Options in Los Angeles, CA

If you're searching for diabetic nephropathies treatment options in Los Angeles, CA, this clinical trial (NCT02986984) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Los Angeles research site is actively enrolling participants for this clinical trial. You'll receive care from experienced diabetic nephropathies specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all diabetic nephropathies clinical trials near you to find additional studies recruiting in your area.

More Essential Tremor Trials in Los Angeles, CA

See all essential tremor clinical trials recruiting in Los Angeles — not just this study.

Browse Essential Tremor Trials in Los Angeles

Ready to Join in Los Angeles?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Los Angeles, CA